Skip to content

Effects of rush component intake on cognitive function in MCI tendencies

Effects of rush component intake on cognitive function in MCI tendencies - Effects of rush component intake on cognitive function in MCI tendencies

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046070
Enrollment
60
Registered
2023-09-16
Start date
2021-11-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

1 grains of the test product daily oral intake for 24 weeks. 1 grains of the placebo daily oral intake for 24 weeks.

Sponsors

EP Mediate Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy men and women between the ages of 65 and 74. (2) Subjects who are aware of forgetting due to aging. (3) Subjects who the average T-score of 6 items of Five Cog are lower than 50 in the screening.

Exclusion criteria

Exclusion criteria: (1) Subjects who constantly use health food richly containing involvement ingredient (2) Subjects who regularly take drugs or health foods which may affect this study more than once a week (3) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire. (4) Subjects suspected of having dementia or mental disorder based on cognitive function tests and physician interviews. (5) Subjects who have performed the cognitive tests within 3 months prior to the screening. (6) Subjects at risk of developing allergy in relation to the study. (7) Subjects who have diseases that require constant medication (excluding high blood pressure, lipid abnormalities and external drugs). (8) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination. (9) Subjects who participated in other clinical studies. (10) Subjects judged as unsuitable for the study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Cognitive function test Evaluate before ingestion and 24 weeks after ingestion.

Secondary

MeasureTime frame
Hearing test, dexterity test, QOL questionnaire Evaluate before ingestion and 24 weeks after ingestion.

Countries

Japan

Contacts

Public ContactShingo Yamamichi

EP Mediate Co., Ltd. Foods Department, Trial Planning Section

yamamichi.shingo578@eps.co.jp090-4821-1099

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026